2020
DOI: 10.3389/fimmu.2020.00886
|View full text |Cite
|
Sign up to set email alerts
|

RANK Ligand Helps Immunity to Leishmania major by Skewing M2-Like Into M1 Macrophages

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 61 publications
1
11
0
Order By: Relevance
“…Fibroblast apoptosis is also induced by upregulating collagenolytic enzymes, prostaglandin E2 (PGE2) and chemokines [ 17 ]. Meanwhile, anti-inflammatory factors can downregulate pro-inflammatory factors and RANKL expression in activated T cells, thereby inhibiting osteoclastogenesis [ 18 ]. Type II diabetes mellitus (T2DM) is a type of metabolic disease caused by deficiency of insulin, where the pathogenesis thereof principally includes insufficient insulin production, insulin malfunction, and lack of insulin receptors on the cell surface, resulting in decreased glucose tolerance and increased blood sugar.…”
Section: Introductionmentioning
confidence: 99%
“…Fibroblast apoptosis is also induced by upregulating collagenolytic enzymes, prostaglandin E2 (PGE2) and chemokines [ 17 ]. Meanwhile, anti-inflammatory factors can downregulate pro-inflammatory factors and RANKL expression in activated T cells, thereby inhibiting osteoclastogenesis [ 18 ]. Type II diabetes mellitus (T2DM) is a type of metabolic disease caused by deficiency of insulin, where the pathogenesis thereof principally includes insufficient insulin production, insulin malfunction, and lack of insulin receptors on the cell surface, resulting in decreased glucose tolerance and increased blood sugar.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, inflammatory monocytes from B6 mice expressed F4/80 int and a M2-like phenotype, characterized by heterogeneous expression of M2 markers such as MGL (CD301), mannose receptor (CD206), IL-4Ra and IL-10 (51). Strikingly, treatment with either RANKL or IFN-g induced monocytes to express F4/80 hi and M1 features, such as IL-12p35 and iNOS expression, IL-12 and TNF-a production, coupled with reduced M2 MGL marker (51). We also observed an intermediate M1-M2 subset, which expressed both MGL and iNOS after treatment with RANKL (51).…”
Section: Targeting Inflammatory Monocytes: Rankl Helps a M2-like To M1 Phenotype Shiftmentioning
confidence: 84%
“…We observed that monocytes secreted IL-12 in response to endogenous RANKL and IFN-g produced during the crosstalk between CD4 T-cells and infected monocytes. In turn, RANKL-stimulated monocytes increased Th1 responses (51). In the next section, we will discuss how RANKL and IFN-g affect the phenotype of inflammatory monocytes to promote immunity to L. major infection (51).…”
Section: Functional Monocyte Responses To Cd4 T-cell Cytokinesmentioning
confidence: 99%
See 2 more Smart Citations